Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning
Version of Record online: 19 JUL 2005
European Journal of Neuroscience
Volume 22, Issue 1, pages 283–287, July 2005
How to Cite
Guigoni, C., Dovero, S., Aubert, I., Li, Q., Bioulac, B. H., Bloch, B., Gurevich, E. V., Gross, C. E. and Bezard, E. (2005), Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning. European Journal of Neuroscience, 22: 283–287. doi: 10.1111/j.1460-9568.2005.04196.x
- Issue online: 19 JUL 2005
- Version of Record online: 19 JUL 2005
- Received 9 March 2005, revised 13 April 2005, accepted 9 May 2005
Fig. S1. Pattern of lesion in control, MPTP-lesioned untreated, MPTP-lesioned LDOPA- treated non-dyskinetic, and L-DOPA-treated dyskinetic monkeys. Representative high power photomicrographs of the striatal sections immunostained for TH shown in figure 1F (top row) and of adjacent striatal sections double-immunolabelled (bottom) for TH (green) and DAT (red). Colocalisation of TH and DAT immunoreactivity produces a yellow signal. Scale bar = 55 ?m. Photomicrographs have been taken in all striatal quadrants at exactly the same position on each section to avoid selection bias: Cdl: caudate dorso-lateral; Cdm: caudate dorso-median; Cvl: caudate ventrolateral; Cvm: caudate ventro-median; Pdl: putamen dorso-lateral; Pdm: putamen dorso-median; Pvl: putamen ventro-lateral; Pvm: putamen ventro-median.
|EJN_4196_sm_FigS1.doc||684K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.